HEALTHCARE
Global Radiopharmaceuticals Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Radiopharmaceuticals Market, By Radioisotope (Technetium-99, Fluorine-18, Iodine-131, Leutetium-177, Yttrium-90, Gallium-68, Gallium-67, Rubidium-82, Iodine-123, Iodine-125, Indium-111, and Others), Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, and Others), Source (Nuclear Reactors and Cyclotrons), End User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Ambulatory Surgical Centers, and Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global radiopharmaceuticals market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
Radiopharmaceuticals are pharmaceutical substances that contain radioactive isotopes and are used for diagnostic and therapeutic purposes in nuclear medicine. To target specific tissues or organs within the body, these chemicals mix a radioactive element with a physiologically active molecule. The radiation released by radioactive isotopes is detected using imaging devices for diagnostic purposes or delivered as targeted radiation for therapeutic purposes.
Radiopharmaceuticals have transformed nuclear medicine by providing essential tools for illness diagnosis, evaluating therapy responses, and delivering tailored medicines. Their use is expanding as researchers investigate new radiolabeling techniques and produce newer radiopharmaceuticals for a variety of medical ailments.
Market Dynamics
DRIVERS
- Technological innovations in radiolabeling techniques
- Increasing demand for personalized medicine
RESTRAINTS
- Complexity of clinical trials
- High cost of production
OPPORTUNITIES
- Globalization and access to healthcare
- Government initiatives and support
CHALLENGES
- Ethical and environmental concerns
- Radiation safety and regulatory compliance
SEGMENTATION
MARKET SEGMENTATION
- Radioisotope
- Technetium-99
- Fluorine-18
- Iodine-131
- Leutetium-177
- Yttrium-90
- Gallium-68
- Gallium-67
- Rubidium-82
- Iodine-123
- Iodine-125
- Indium-111
- Others
- Type
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceutical
- Application
- Oncology
- Cardiology
- Gastroenterology
- Neuroendocrinology
- Neurology
- Nephrology
- Others
- Source
- Nuclear Reactors
- Cyclotrons
- End User
- Hospitals
- Diagnostic Centers
- Cancer Research Institutes
- Ambulatory Surgical Centers
- Others
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Cardinal Health
- Advanced Accelerator Applications
- A Novartis Company
- Lantheus
- Curium
- GE HealthCare
- Jubilant Radiopharma
- China lsotope & Radiation Corporation.
- Siemens Healthcare GmbH
- Bracco
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Radiopharmaceuticals Market, by Radioisotope
- 3.2 Global Radiopharmaceuticals Market, by Type
- 3.3 Global Radiopharmaceuticals Market, by Application
- 3.4 Global Radiopharmaceuticals Market, by Source
- 3.5 Global Radiopharmaceuticals Market, by End User
- 3.6 Global Radiopharmaceuticals Market, by Geography
- 3.7 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Trend 1
- 5.1.2 Trend 2
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Technological innovations in radiolabeling techniques
- 5.2.2 Increasing demand for personalized medicine
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 Complexity of clinical trials
- 5.3.2 High cost of production
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Globalization and access to healthcare
- 5.4.2 Government initiatives and support
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Ethical and environmental concerns
- 5.5.2 Radiation safety and regulatory compliance
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL RADIOPHARMACEUTICALS MARKET, BY RADIOISOTOPE
- 6.1 Radioisotope Summary
- 6.2 Market Attractive Index
- 6.3 Global Radiopharmaceuticals Market, by Radioisotope (2019-2032)
- SECTION 7 - GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE
- 7.1 Type Summary
- 7.2 Market Attractive Index
- 7.3 Global Radiopharmaceuticals Market, by Type (2019-2032)
- SECTION 8 - GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION
- 8.1 Application Summary
- 8.2 Market Attractive Index
- 8.3 Global Radiopharmaceuticals Market, by Application (2019-2032)
- SECTION 9 - GLOBAL RADIOPHARMACEUTICALS MARKET, BY SOURCE
- 9.1 Source Summary
- 9.2 Market Attractive Index
- 9.3 Global Radiopharmaceuticals Market, by Source (2019-2032)
- SECTION 10 - GLOBAL RADIOPHARMACEUTICALS MARKET, BY END USER
- 10.1 End User Summary
- 10.2 Market Attractive Index
- 10.3 Global Radiopharmaceuticals Market, by End User (2019-2032)
- SECTION 11 - GLOBAL RADIOPHARMACEUTICALS MARKET, BY GEOGRAPHY
- 11.1 Regional Summary
- 11.2 Market Attractive Index
- 11.3 Global Radiopharmaceuticals Market, by Geography (2019-2032)
- SECTION 12 - NORTH AMERICA RADIOPHARMACEUTICALS MARKET
- 12.1 North America Summary
- 12.2 Market Attractive Index
- 12.3 North America Radiopharmaceuticals Market, by Radioisotope (2019-2032)
- 12.4 North America Radiopharmaceuticals Market, by Type (2019-2032)
- 12.5 North America Radiopharmaceuticals Market, by Application (2019-2032)
- 12.6 North America Radiopharmaceuticals Market, by Source (2019-2032)
- 12.7 North America Radiopharmaceuticals Market, by End User (2019-2032)
- 12.8 North America Radiopharmaceuticals Market, by Country (2019-2032)
- 12.8.1 U.S.
- 12.8.2 Canada
- 12.8.3 Mexico
- 12.8.4 Rest of North America
- SECTION 13 - EUROPE RADIOPHARMACEUTICALS MARKET
- 13.1 Europe Summary
- 13.2 Market Attractive Index
- 13.3 Europe Radiopharmaceuticals Market, by Radioisotope (2019-2032)
- 13.4 Europe Radiopharmaceuticals Market, by Type (2019-2032)
- 13.5 Europe Radiopharmaceuticals Market, by Application (2019-2032)
- 13.6 Europe Radiopharmaceuticals Market, by Source (2019-2032)
- 13.7 Europe Radiopharmaceuticals Market, by End User (2019-2032)
- 13.8 Europe Radiopharmaceuticals Market, by Country (2019-2032)
- 13.8.1 Germany
- 13.8.2 U.K.
- 13.8.3 France
- 13.8.4 Italy
- 13.8.5 Spain
- 13.8.6 Russia
- 13.8.7 The Netherlands
- 13.8.8 Belgium
- 13.8.9 Turkey
- 13.8.10 Rest of Europe
- SECTION 14 - ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET
- 14.1 Asia-Pacific Summary
- 14.2 Market Attractive Index
- 14.3 Asia-Pacific Radiopharmaceuticals Market, by Radioisotope (2019-2032)
- 14.4 Asia-Pacific Radiopharmaceuticals Market, by Type (2019-2032)
- 14.5 Asia-Pacific Radiopharmaceuticals Market, by Application (2019-2032)
- 14.6 Asia-Pacific Radiopharmaceuticals Market, by Source (2019-2032)
- 14.7 Asia-Pacific Radiopharmaceuticals Market, by End User (2019-2032)
- 14.8 Asia-Pacific Radiopharmaceuticals Market, by Country (2019-2032)
- 14.8.1 China
- 14.8.2 India
- 14.8.3 Japan
- 14.8.4 South Korea
- 14.8.5 Singapore
- 14.8.6 Malaysia
- 14.8.7 Australia
- 14.8.8 Thailand
- 14.8.9 Philippines
- 14.8.10 Rest of Asia-Pacific
- SECTION 15 - SOUTH AMERICA RADIOPHARMACEUTICALS MARKET
- 15.1 South America Summary
- 15.2 Market Attractive Index
- 15.3 South America Radiopharmaceuticals Market, by Radioisotope (2019-2032)
- 15.4 South America Radiopharmaceuticals Market, by Type (2019-2032)
- 15.5 South America Radiopharmaceuticals Market, by Application (2019-2032)
- 15.6 South America Radiopharmaceuticals Market, by Source (2019-2032)
- 15.7 South America Radiopharmaceuticals Market, by End User (2019-2032)
- 15.8 South America Radiopharmaceuticals Market, by Country (2019-2032)
- 15.8.1 Brazil
- 15.8.2 Argentina
- 15.8.3 Chile
- 15.8.4 Colombia
- 15.8.5 Rest of South America
- SECTION 16 - MIDDLE EAST AND AFRICA RADIOPHARMACEUTICALS MARKET
- 16.1 Middle East and Africa Summary
- 16.2 Market Attractive Index
- 16.3 Middle East and Africa Radiopharmaceuticals Market, by Radioisotope (2019-2032)
- 16.4 Middle East and Africa Radiopharmaceuticals Market, by Type (2019-2032)
- 16.5 Middle East and Africa Radiopharmaceuticals Market, by Application (2019-2032)
- 16.6 Middle East and Africa Radiopharmaceuticals Market, by Source (2019-2032)
- 16.7 Middle East and Africa Radiopharmaceuticals Market, by End User (2019-2032)
- 16.8 Middle East and Africa Radiopharmaceuticals Market, by Country (2019-2032)
- 16.8.1 Kingdom of Saudi Arabia
- 16.8.2 South Africa
- 16.8.3 U.A.E.
- 16.8.4 Egypt
- 16.8.5 Rest of Middle East and Africa
- SECTION 17 - COMPANY SHARE ANALYSIS
- 17.1 Global Radiopharmaceuticals Market, Company Share Analysis
- 17.2 North America Radiopharmaceuticals Market, Company Share Analysis
- 17.3 Europe Radiopharmaceuticals Market, Company Share Analysis
- 17.4 Asia-Pacific Radiopharmaceuticals Market, Company Share Analysis
- SECTION 18 - COMPANY PROFILES
- 18.1 Cardinal Health
- 18.1.1 Company Snapshot
- 18.1.2 Financial Overview
- 18.1.3 Product Portfolio
- 18.1.4 Recent Developments
- 18.2 Advanced Accelerator Applications
- 18.2.1 Company Snapshot
- 18.2.2 Financial Overview
- 18.2.3 Product Portfolio
- 18.2.4 Recent Developments
- 18.3 A Novartis Company
- 18.3.1 Company Snapshot
- 18.3.2 Financial Overview
- 18.3.3 Product Portfolio
- 18.3.4 Recent Developments
- 18.4 Lantheus
- 18.4.1 Company Snapshot
- 18.4.2 Financial Overview
- 18.4.3 Product Portfolio
- 18.4.4 Recent Developments
- 18.5 Curium
- 18.5.1 Company Snapshot
- 18.5.2 Financial Overview
- 18.5.3 Product Portfolio
- 18.5.4 Recent Developments
- 18.6 GE HealthCare
- 18.6.1 Company Snapshot
- 18.6.2 Financial Overview
- 18.6.3 Product Portfolio
- 18.6.4 Recent Developments
- 18.7 Jubilant Radiopharma
- 18.7.1 Company Snapshot
- 18.7.2 Financial Overview
- 18.7.3 Product Portfolio
- 18.7.4 Recent Developments
- 18.8 China lsotope & Radiation Corporation.
- 18.8.1 Company Snapshot
- 18.8.2 Financial Overview
- 18.8.3 Product Portfolio
- 18.8.4 Recent Developments
- 18.9 Siemens Healthcare GmbH
- 18.9.1 Company Snapshot
- 18.9.2 Financial Overview
- 18.9.3 Product Portfolio
- 18.9.4 Recent Developments
- 18.10 Bracco
- 18.10.1 Company Snapshot
- 18.10.2 Financial Overview
- 18.10.3 Product Portfolio
- 18.10.4 Recent Developments
- SECTION 19 - RELATED REPORTS
- SECTION 20 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.